Azacitidine effectively reduces TP53-mutant leukemic cell burden in secondary acute myeloid leukemia after cord blood transplantation. Issue 11 (2nd November 2018) - Takei, Tomomi; Yokoyama, Kazuaki; Shimizu, Eigo; Konuma, Takaaki; Takahashi, Satoshi; Yamaguchi, Rui; Imoto, Seiya; Miyano, Satoru; Tojo, Arinobu